Answers are grounded in this paper and cite their sources.
Today, every tenth European takes proton pump inhibitors (PPI) on a regular basis. PPIs are safe drugs; still, their continuous intake increases the possibility of adverse events significantly. There is evidence that long-term use of PPIs is associated with a higher cardiovascular risk, the risk of synergism and antagonism of drug interactions with PPIs, digestive infections, kidney diseases, dementia, malabsorption syndrome, oncological diseases, myopathy, and microscopic colitis. Therefore, a search for optimal ways of using PPIs and prevention of possible side effects with their long-term use is an acute medico-social issue. This is especially true considering that about half of PPI prescription cases do not include a proper assessment of the PPI feasibility. The article aims to describe the side effects of long-term use of PPI and measures to prevent them, considering the achievements of modern gastroenterology.
No takes yet. Share an insight, caveat, or question.
Осадчук et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: